CD274 and neoplasm: Moreover, TAMs could also express PD-L1 to inhibit tumor immunity and phagocytosis (Gordon et al., 2017), an essential target immune checkpoint inhibitor to enhance anti-tumor immunity (Cha et al., 2019).